A citation-based method for searching scientific literature

Chong-Bin Zhu, Randy D Blakely, William A Hewlett. Neuropsychopharmacology 2006
Times Cited: 341







List of co-cited articles
1552 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Interleukin-1 receptor activation by systemic lipopolysaccharide induces behavioral despair linked to MAPK regulation of CNS serotonin transporters.
Chong-Bin Zhu, Kathryn M Lindler, Anthony W Owens, Lynette C Daws, Randy D Blakely, William A Hewlett. Neuropsychopharmacology 2010
184
33

A meta-analysis of cytokines in major depression.
Yekta Dowlati, Nathan Herrmann, Walter Swardfager, Helena Liu, Lauren Sham, Elyse K Reim, Krista L Lanctôt. Biol Psychiatry 2010
31

From inflammation to sickness and depression: when the immune system subjugates the brain.
Robert Dantzer, Jason C O'Connor, Gregory G Freund, Rodney W Johnson, Keith W Kelley. Nat Rev Neurosci 2008
29

A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers.
Charles L Raison, Robin E Rutherford, Bobbi J Woolwine, Chen Shuo, Pamela Schettler, Daniel F Drake, Ebrahim Haroon, Andrew H Miller. JAMA Psychiatry 2013
859
21

Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.
M Bryant Howren, Donald M Lamkin, Jerry Suls. Psychosom Med 2009
21

Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression.
Andrew H Miller, Vladimir Maletic, Charles L Raison. Biol Psychiatry 2009
21

p38 MAPK activation elevates serotonin transport activity via a trafficking-independent, protein phosphatase 2A-dependent process.
Chong-Bin Zhu, Ana M Carneiro, Wolfgang R Dostmann, William A Hewlett, Randy D Blakely. J Biol Chem 2005
155
17


Cytokines sing the blues: inflammation and the pathogenesis of depression.
Charles L Raison, Lucile Capuron, Andrew H Miller. Trends Immunol 2006
16

Inflammation is associated with decreased functional connectivity within corticostriatal reward circuitry in depression.
J C Felger, Z Li, E Haroon, B J Woolwine, M Y Jung, X Hu, A H Miller. Mol Psychiatry 2016
244
15

Inflammation and clinical response to treatment in depression: A meta-analysis.
R Strawbridge, D Arnone, A Danese, A Papadopoulos, A Herane Vives, A J Cleare. Eur Neuropsychopharmacol 2015
289
15

Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice.
J C O'Connor, M A Lawson, C André, M Moreau, J Lestage, N Castanon, K W Kelley, R Dantzer. Mol Psychiatry 2009
750
13

Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein in patients with major depressive disorder.
Rita Haapakoski, Julia Mathieu, Klaus P Ebmeier, Harri Alenius, Mika Kivimäki. Brain Behav Immun 2015
453
13

Cytokine targets in the brain: impact on neurotransmitters and neurocircuits.
Andrew H Miller, Ebrahim Haroon, Charles L Raison, Jennifer C Felger. Depress Anxiety 2013
369
13

Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions.
Lucile Capuron, Jane F Gumnick, Dominique L Musselman, David H Lawson, Andrea Reemsnyder, Charles B Nemeroff, Andrew H Miller. Neuropsychopharmacology 2002
502
12


Dopaminergic mechanisms of reduced basal ganglia responses to hedonic reward during interferon alfa administration.
Lucile Capuron, Giuseppe Pagnoni, Daniel F Drake, Bobbi J Woolwine, James R Spivey, Ronald J Crowe, John R Votaw, Mark M Goodman, Andrew H Miller. Arch Gen Psychiatry 2012
214
12

Evidence for increased microglial priming and macrophage recruitment in the dorsal anterior cingulate white matter of depressed suicides.
Susana G Torres-Platas, Cristiana Cruceanu, Gary Gang Chen, Gustavo Turecki, Naguib Mechawar. Brain Behav Immun 2014
231
12


Cytokine production and treatment response in major depressive disorder.
S Lanquillon, J C Krieg, U Bening-Abu-Shach, H Vedder. Neuropsychopharmacology 2000
502
12

Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials.
Ole Köhler, Michael E Benros, Merete Nordentoft, Michael E Farkouh, Rupa L Iyengar, Ole Mors, Jesper Krogh. JAMA Psychiatry 2014
441
12

CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression.
C L Raison, R Dantzer, K W Kelley, M A Lawson, B J Woolwine, G Vogt, J R Spivey, K Saito, A H Miller. Mol Psychiatry 2010
407
11

Tyrosine metabolism during interferon-alpha administration: association with fatigue and CSF dopamine concentrations.
Jennifer C Felger, Li Li, Paul J Marvar, Bobbi J Woolwine, David G Harrison, Charles L Raison, Andrew H Miller. Brain Behav Immun 2013
97
11


Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes.
Elaine Setiawan, Alan A Wilson, Romina Mizrahi, Pablo M Rusjan, Laura Miler, Grazyna Rajkowska, Ivonne Suridjan, James L Kennedy, P Vivien Rekkas, Sylvain Houle,[...]. JAMA Psychiatry 2015
409
11

Chronic immune stimulation correlates with reduced phenylalanine turnover.
G Neurauter, K Schröcksnadel, S Scholl-Bürgi, B Sperner-Unterweger, C Schubert, M Ledochowski, D Fuchs. Curr Drug Metab 2008
154
11


Interferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatment.
Lucile Capuron, Gabriele Neurauter, Dominique L Musselman, David H Lawson, Charles B Nemeroff, Dietmar Fuchs, Andrew H Miller. Biol Psychiatry 2003
319
10

Mitogen-activated protein kinase regulates dopamine transporter surface expression and dopamine transport capacity.
José A Morón, Irina Zakharova, Jasmine V Ferrer, Gerald A Merrill, Bruce Hope, Eileen M Lafer, Zhi Cheng Lin, Jia Bei Wang, Jonathan A Javitch, Aurelio Galli,[...]. J Neurosci 2003
167
10

Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: evidence for an immune-modulated glutamatergic neurotransmission?
Johann Steiner, Martin Walter, Tomasz Gos, Gilles J Guillemin, Hans-Gert Bernstein, Zoltán Sarnyai, Christian Mawrin, Ralf Brisch, Hendrik Bielau, Louise Meyer zu Schwabedissen,[...]. J Neuroinflammation 2011
334
10

Individual differences in the peripheral immune system promote resilience versus susceptibility to social stress.
Georgia E Hodes, Madeline L Pfau, Marylene Leboeuf, Sam A Golden, Daniel J Christoffel, Dana Bregman, Nicole Rebusi, Mitra Heshmati, Hossein Aleyasin, Brandon L Warren,[...]. Proc Natl Acad Sci U S A 2014
343
10

Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity.
Neil A Harrison, Lena Brydon, Cicely Walker, Marcus A Gray, Andrew Steptoe, Hugo D Critchley. Biol Psychiatry 2009
432
10

Pro-inflammatory cytokines and treatment response to escitalopram in major depressive disorder.
Triin Eller, Veiko Vasar, Jakov Shlik, Eduard Maron. Prog Neuropsychopharmacol Biol Psychiatry 2008
207
10

Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies.
C A Köhler, T H Freitas, M Maes, N Q de Andrade, C S Liu, B S Fernandes, B Stubbs, M Solmi, N Veronese, N Herrmann,[...]. Acta Psychiatr Scand 2017
435
10

Inflammation-associated depression: from serotonin to kynurenine.
Robert Dantzer, Jason C O'Connor, Marcus A Lawson, Keith W Kelley. Psychoneuroendocrinology 2011
437
9

Paroxetine for the prevention of depression induced by high-dose interferon alfa.
D L Musselman, D H Lawson, J F Gumnick, A K Manatunga, S Penna, R S Goodkin, K Greiner, C B Nemeroff, A H Miller. N Engl J Med 2001
730
9

Peripheral inflammation is associated with altered substantia nigra activity and psychomotor slowing in humans.
Lena Brydon, Neil A Harrison, Cicely Walker, Andrew Steptoe, Hugo D Critchley. Biol Psychiatry 2008
210
9

Conceptual convergence: increased inflammation is associated with increased basal ganglia glutamate in patients with major depression.
E Haroon, C C Fleischer, J C Felger, X Chen, B J Woolwine, T Patel, X P Hu, A H Miller. Mol Psychiatry 2016
116
9


Inflammation-induced anhedonia: endotoxin reduces ventral striatum responses to reward.
Naomi I Eisenberger, Elliot T Berkman, Tristen K Inagaki, Lian T Rameson, Nehjla M Mashal, Michael R Irwin. Biol Psychiatry 2010
318
9

The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine.
N Müller, M J Schwarz, S Dehning, A Douhe, A Cerovecki, B Goldstein-Müller, I Spellmann, G Hetzel, K Maino, N Kleindienst,[...]. Mol Psychiatry 2006
511
9

Inflammation, Glutamate, and Glia: A Trio of Trouble in Mood Disorders.
Ebrahim Haroon, Andrew H Miller, Gerard Sanacora. Neuropsychopharmacology 2017
149
9

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report.
A John Rush, Madhukar H Trivedi, Stephen R Wisniewski, Andrew A Nierenberg, Jonathan W Stewart, Diane Warden, George Niederehe, Michael E Thase, Philip W Lavori, Barry D Lebowitz,[...]. Am J Psychiatry 2006
9

Basal ganglia hypermetabolism and symptoms of fatigue during interferon-alpha therapy.
Lucile Capuron, Giuseppe Pagnoni, Marina F Demetrashvili, David H Lawson, Fiona B Fornwalt, Bobbi Woolwine, Gregory S Berns, Charles B Nemeroff, Andrew H Miller. Neuropsychopharmacology 2007
162
8

Induction of IDO by bacille Calmette-Guérin is responsible for development of murine depressive-like behavior.
Jason C O'Connor, Marcus A Lawson, Caroline André, Eileen M Briley, Sandra S Szegedi, Jacques Lestage, Nathalie Castanon, Miles Herkenham, Robert Dantzer, Keith W Kelley. J Immunol 2009
198
8

Candidate genes expression profile associated with antidepressants response in the GENDEP study: differentiating between baseline 'predictors' and longitudinal 'targets'.
Annamaria Cattaneo, Massimo Gennarelli, Rudolf Uher, Gerome Breen, Anne Farmer, Katherine J Aitchison, Ian W Craig, Christoph Anacker, Patricia A Zunsztain, Peter McGuffin,[...]. Neuropsychopharmacology 2013
268
8

Prefrontal cortical hypometabolism during low-dose interferon alpha treatment.
F D Juengling, D Ebert, O Gut, M A Engelbrecht, J Rasenack, E U Nitzsche, J Bauer, K Lieb. Psychopharmacology (Berl) 2000
114
8


Neuropsychiatric adverse effects of interferon-alpha: recognition and management.
Charles L Raison, Marina Demetrashvili, Lucile Capuron, Andrew H Miller. CNS Drugs 2005
328
8

Chronic low-grade inflammation in elderly persons is associated with altered tryptophan and tyrosine metabolism: role in neuropsychiatric symptoms.
Lucile Capuron, Sebastian Schroecksnadel, Catherine Féart, Agnès Aubert, Denise Higueret, Pascale Barberger-Gateau, Sophie Layé, Dietmar Fuchs. Biol Psychiatry 2011
205
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.